FDA Approves Aristada Initio to Allow Immediate Initiation of the Long-Acting Atypical Antipsychotic
Clinicians will soon be able to offer patients with schizophrenia who are initiating the long-acting...
Clinicians will soon be able to offer patients with schizophrenia who are initiating the long-acting...
Regular use of a mobile-based intervention may benefit young people with recent-onset schizophrenia ...
Patients with early-phase psychosis who received integrated, coordinated antipsychotic treatment and...
An estimated 25% to 50% of patients diagnosed with schizotypal disorder develop schizophrenia within...
Many guidelines for treating patients with schizophrenia with antipsychotics recommend that after st...
Patients experiencing a first episode of schizophrenia-spectrum disorder who participate in an early...
A meta-analysis in Schizophrenia Bulletin found that rates of victimization were between 4 and 6 tim...
Adolescents whose asthma required hospitalization may be at a greater risk of developing bipolar dis...
Electroconvulsive therapy (ECT) does not appear to increase long-term dementia risk in patients, acc...